News + Filings Transactions Holdings
All 13F 13D/G Other
|
TYBOURNE CAPITAL MANAGEMENT (HK) LTD
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2023 |
SC 13G
| TYBOURNE CAPITAL MANAGEMENT LTD reports a 3.9% stake in Zentalis Pharmaceuticals, LLC |
02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
05/11/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
05/03/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
03/14/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/24/2022 |
13F-HR/A
| Form 13F-HR/A - Quarterly report filed by institutional managers, Holdings: [Amend] |
02/14/2022 |
SC 13G
| TYBOURNE CAPITAL MANAGEMENT LTD reports a 5.8% stake in Zentalis Pharmaceuticals, LLC |
01/25/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
01/03/2022 |
SC 13G/A
| TYBOURNE CAPITAL MANAGEMENT LTD reports a 0% stake in TPG Pace Beneficial Finance Corp. |
01/03/2022 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Sold 4,817,252 shares
@ $9.8062, valued at
$47.2M
|
|
12/17/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Sold 50,000 shares
@ $10.0057, valued at
$500.3k
|
|
12/16/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Sold 40,050 shares
@ $10.0727, valued at
$403.4k
|
|
12/15/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Sold 50,000 shares
@ $10.1463, valued at
$507.3k
|
|
07/21/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
04/13/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
04/09/2021 |
SC 13G
| TYBOURNE CAPITAL MANAGEMENT LTD reports a 14.2% stake in TPG Pace Beneficial Finance Corp. |
03/23/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Bought 146,836 shares
@ $19.5886, valued at
$2.9M
|
|
03/22/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Bought 390 shares
@ $18.9413, valued at
$7.4k
Bought 273,910 shares
@ $19.4659, valued at
$5.3M
Bought 700 shares
@ $20, valued at
$14k
|
|
03/18/2021 |
4
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 4 on TPG Pace Beneficial Finance Corp.
Txns:
| Bought 195,000 shares
@ $19.8651, valued at
$3.9M
Bought 32,037 shares
@ $18.7732, valued at
$601.4k
Bought 326,119 shares
@ $19.7229, valued at
$6.4M
|
|
03/18/2021 |
3
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD (10% Owner) has filed a Form 3 on TPG Pace Beneficial Finance Corp. |
02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2021 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
11/12/2020 |
SC 13D/A
| TYBOURNE CAPITAL MANAGEMENT LTD reports a 7.5% stake in Bicycle Therapeutics Limited |
11/09/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
08/12/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
07/20/2020 |
SC 13D/A
| TYBOURNE CAPITAL MANAGEMENT HK LTD reports a 8.8% stake in Bicycle Therapeutics Limited |
05/29/2020 |
SC 13G
| TYBOURNE CAPITAL MANAGEMENT HK LTD reports a 7.4% stake in Zentalis Pharmaceuticals, LLC |
05/15/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
02/14/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2020 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
|
|
|